Andy Holt

Andy is the Chief Commercial Officer for Viralgen, an AAV-focused CDMO. His focus throughout his career has been working in cell and gene therapy testing, development and manufacturing at both CDMOs and therapeutic developers in commercial roles, working to find ways to expand the reach and lower the cost of these revolutionary medicines.